title: The prospective protective effect of selenium nanoparticles against chromium-induced oxidative and cellular damage in rat thyroid.
abstract: BACKGROUND
  Nanotechnology has enabled researchers to synthesize nanosize particles that possess increased surface areas. Compared to conventional microparticles, it has resulted in increased interactions with biological targets.
  
  
  OBJECTIVE
  The objective of this study was to determine the protective ability of selenium nanoparticles against hexavalent chromium-induced thyrotoxicity.
  
  
  METHODS
  Twenty male rats were used in the study, and arbitrarily assigned to four groups. Group 1 was the control group, and was given phosphate-buffered saline. Group 2 was the chromium-treated group and was given K2Cr2O7 60 μg/kg body weight intraperitoneally as a single dose on the third day of administration. Group 3 was the nano-selenium-treated group and was given selenium nanoparticles (size 3-20 nm) 0.5 mg/kg body weight intraperitoneally daily for 5 consecutive days. Group 4 was the nano-selenium chromium-treated group, which received selenium nanoparticles for 5 days and a single dose of K2Cr2O7 on the third day of administration.
  
  
  METHODS
  Blood samples were collected from rats for measuring thyroid hormones (free triiodothyronine [T3] and free thyroxine [T4]) and oxidative and antioxidant parameters (malondialdehyde [MDA], reduced glutathione [GSH], catalase, and superoxide dismutase [SOD]). Upon dissection, thyroid glands were taken for histopathological examination by using paraffin preparations stained with hematoxylin and eosin (H&E) and Masson's trichrome. Immunohistochemical staining was performed for detecting cellular proliferation using Ki67 antibodies.
  
  
  RESULTS
  The present study shows that K2Cr2O7 has a toxic effect on the thyroid gland as a result of inducing a marked oxidative damage and release of reactive oxygen species. This was shown by the significant decrease in free T3 and T4 and GSH levels, which was accompanied by significant increases in catalase, SOD, and MDA in the chromium-treated group compared to the control group. Se nanoparticles have a protective effect on K2Cr2O7-induced thyroid damage, as a result of correcting the free T3 and T4 levels and GSH, catalase, SOD, and MDA compared to the K2Cr2O7-treated group. Administration of nano-selenium alone in the nano-selenium-treated group had no toxic effect on rats' thyroid compared to the control group. The biochemical results were confirmed by histopathological, immunohistochemical and pathomorphological studies.
authors: Department of Biochemistry, Faculty of Veterinary Medicine, Beni-Suef University, Beni-Suef, Egypt.
authors: Kamel M A
authors: KM
authors: Hassanin
authors: Samraa H
authors: SH
authors: Abd El-Kawi
authors: Khalid S
authors: KS
authors: Hashem
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000032:analysis; D002374:Catalase / Q000097:blood; D002857:Chromium / Q000633:toxicity*; D005979:Glutathione Peroxidase / Q000097:blood; D007150:Immunohistochemistry; D008297:Male; D008315:Malondialdehyde / Q000097:blood; D053758:Nanoparticles / Q000737:chemistry*; D018384:Oxidative Stress / Q000187:drug effects*; D020011:Protective Agents / Q000737:chemistry / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012643:Selenium / Q000737:chemistry / Q000494:pharmacology*; D013482:Superoxide Dismutase / Q000097:blood; D013961:Thyroid Gland / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D013963:Thyroid Hormones / Q000097:blood
chemical_list: D000975:Antioxidants; D020011:Protective Agents; D013963:Thyroid Hormones; D002857:Chromium; D008315:Malondialdehyde; D002374:Catalase; D005979:Glutathione Peroxidase; D013482:Superoxide Dismutase; D012643:Selenium
keywords: chromium; protective effect; selenium nanoparticles; thyrotoxicity
references: Eur J Endocrinol. 2004 Jun;150(6):841-9
references: 15191356
references: Arch Toxicol. 2002 Jun;76(5-6):269-76
references: 12107644
references: Free Radic Biol Med. 2002 May 1;32(9):822-32
references: 11978484
references: J Inorg Biochem. 2007 Oct;101(10):1457-63
references: 17664013
references: J Biol Chem. 1999 Dec 3;274(49):34974-80
references: 10574974
references: Science. 2006 Feb 3;311(5761):622-7
references: 16456071
references: Toxicology. 2002 Oct 30;180(1):5-22
references: 12324196
references: Toxicol Ind Health. 2010 Jul;26(6):349-59
references: 20504825
references: Clin Chim Acta. 1978 Nov 15;90(1):37-43
references: 719890
references: J Lab Clin Med. 1963 May;61:882-8
references: 13967893
references: Environ Health Perspect. 2005 Jul;113(7):823-39
references: 16002369
references: Environ Health Perspect. 1991 May;92:53-62
references: 1657590
references: Int J Nanomedicine. 2011 Jan 17;6:143-9
references: 21289991
references: J Toxicol Clin Toxicol. 1999;37(2):173-94
references: 10382554
references: Biofactors. 2001;15(1):27-38
references: 11673642
references: Adv Food Nutr Res. 2003;47:73-112
references: 14639782
references: Life Sci. 2005 Jan 21;76(10):1099-109
references: 15620574
references: Biochem Biophys Res Commun. 1987 Dec 31;149(3):889-96
references: 3122747
references: Biochem Biophys Res Commun. 1972 Jan 31;46(2):849-54
references: 4400444
references: IUBMB Life. 2000 May;49(5):411-20
references: 10902573
references: J Physiol Pharmacol. 2001 Jun;52(2):275-84
references: 11453106
references: BMC Public Health. 2011 Apr 12;11:224
references: 21481275
references: Histol Histopathol. 2010 Nov;25(11):1355-70
references: 20865659
references: Anal Biochem. 1979 Jun;95(2):351-8
references: 36810
references: Br J Nutr. 2008 Aug;100(2):238-53
references: 18346307
references: Toxicol Sci. 2007 Jul;98(1):298-309
references: 17420218
references: Arch Fam Med. 1999 Sep-Oct;8(5):386-90
references: 10500510
references: Toxicol Sci. 2011 Sep;123(1):58-70
references: 21712504
references: Free Radic Biol Med. 2007 May 15;42(10):1524-33
references: 17448899
references: Chemosphere. 2006 Nov;65(6):913-21
references: 16678235
references: J Nutr. 2006 May;136(5):1311-7
references: 16614422
references: Lancet. 2000 Jul 15;356(9225):233-41
references: 10963212
references: Nutr Rev. 2006 Mar;64(3):146-51
references: 16572602
references: Methods Enzymol. 2002;347:84-100
references: 11898441
references: Best Pract Res Clin Endocrinol Metab. 2009 Dec;23(6):815-27
references: 19942156
references: Vet Pathol. 2011 Nov;48(6):1085-93
references: 21441110